A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells
Aubin Michalon(Light Chain Bioscience (Switzerland)), Jan Grimm(Light Chain Bioscience (Switzerland))
Cited by 95
Related Papers
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid
|New England Journal of Medicine|2023|233